首页> 外国专利> RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1

RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1

机译:在非洲绿色猴子和人肺气道上皮细胞中,含有突变或缺失C蛋白的重组人帕氏肺炎1型病毒(HPIV1s)在HPIV1中有潜在的疫苗候选作用。

摘要

Two recently characterized live attenuated HPIV1 vaccine candidates, rHPIV1-CR84G/Δ170HNT553ALY942A and rHPIV1-CR84G/Δ170HN-T553ALΔ1710-11, which contain temperature sensitive (ts) attenuating (att) and non-ts att mutations, were evaluated in a Human Airway Epithelium (HAE) model culture system and in vivo in African Green monkeys (AGM). The vaccine candidates were highly restricted in growth in HAE at permissive (32° C.) and restrictive (37° C.) temperatures. The viruses grew slightly better at 37° C. than at 32° C., and rHPIV1-CR84G/Δ170HNT553A-LY942A was less attenuated than rHPIV1-CR84G/Δ170HNT553ALΔ1710-11. The level of replication in HAE correlated with that observed in African Green monkeys, suggesting that the HAE model is useful as a tool for pre-clinical evaluation of HPIV1 vaccines. A live attenuated HPIV1 vaccine candidate having a normal P/C gene structure of overlapping P and C open reading frames, but does not express any functional C protein, is found to highly attenuated in AGMs, and provides a significant immune response in AGMs.
机译:最近鉴定的两种减毒活HPIV1候选疫苗rHPIV1-C R84G /Δ170 HN T553A L Y942A 和rHPIV1-C R84G /Δ170在人呼吸道中评估了 HN -T553A L Δ1710-11,其中包含对温度敏感(ts)衰减(att)和非ts att突变上皮(HAE)模型培养系统和非洲绿猴(AGM)体内。候选疫苗在许可温度(32℃)和限制性温度(37℃)下HAE的生长受到高度限制。该病毒在37°C时比在32°C时生长更好,而rHPIV1-C R84G /Δ170 HN T553A -L Y942A 与rHPIV1-CR 84G /Δ170 HN T553A L Δ1710-11相比衰减较小。 HAE中的复制水平与非洲绿猴中观察到的水平相关,这表明HAE模型可用作临床前评估HPIV1疫苗的工具。具有正常的P / C基因结构,重叠的P和C开放阅读框,但不表达任何功能性C蛋白的减毒活HPIV1候选疫苗在AGM中被高度减毒,并在AGM中提供了重要的免疫应答。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号